Management of severe bacterial infections

References

• Juthani-Mehta M, Quagliarello VJ. Prognostic scoring systems for infectious disease: their applicability to the care of older adults. Clin. Infect. Dis. 38(5), 692–696 (2004).
   PubMedGoogle Scholar
• Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31(Suppl. 4), 131–138 (2000).
   PubMedGoogle Scholar
• Edmond MB, Ober JF, Weinbaum DL et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 20(5), 1126–1133 (1995).
   PubMed Web of Science ®Google Scholar
• Husni RN, Goldstein LS, Arroliga AC et al. Risk factors for an outbreak of multi-drug resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 115(5), 1378–1382 (1999).
   PubMed Web of Science ®Google Scholar
• Schentag JJ, Hyatt JM, Carr JR et al. Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin. Infect. Dis. 26(5), 1204–1214 (1998).
   PubMed Web of Science ®Google Scholar
• Owens G, Felts JA, Spitznagel EL. ASA physical status classification: a study consistency of ratings. Anesthesiology 49(4), 239–243 (1978).
   PubMedGoogle Scholar
• Knaus WA, Draper EA, Wagner EA, Zimmerman JE. APACHE II: a severity of disease classification system. Crit. Care Med. 13(10), 818–829 (1985).
   PubMed Web of Science ®Google Scholar
• B’Erard F, Gandon J. Postoperative wound infections: the influence of ultraviolet irradiation of the operating room and various other factors. Ann. Surg. 160(Suppl. 1), 1–192 (1964).
   Google Scholar
• Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 336(4), 243–250 (1997).
   PubMed Web of Science ®Google Scholar
• Vales EC, Abraira V, Sanchez JC et al. A predictive model for mortality of bloodstream infections: bedside analysis with the Weibull function. J. Clin. Epidemiol. 55(6), 563–572 (2002).
   PubMedGoogle Scholar
• Esposito S, Leone S, Noviello S, Ianniello F. Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey. Infez. Med. 12(2), 90–100 (2004).
   PubMedGoogle Scholar
• Baughman RP, Tapson V, McIvor A. The diagnosis and treatment challenges in nosocomial pneumonia. Diagn. Microbiol. Infect. Dis. 33(2), 131–139 (1999).
   PubMed Web of Science ®Google Scholar
• Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society. Am. J. Respir. Crit. Care Med. 153(5), 1711–1725 (1996).
   Google Scholar
• Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348(16), 1546–1554 (2003).
   PubMed Web of Science ®Google Scholar
• Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit. Care Med. 26(12) 2078–2086 (1998).
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 365(9453), 63–78 (2005).
   PubMed Web of Science ®Google Scholar
• Carlet J, Ben Ali A, Chalfine A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr. Opin. Infect. Dis. 17(4), 309–316 (2004).
   PubMed Web of Science ®Google Scholar
• Viscoli C. Management of infection in cancer patients. Studies of the EORTC International Antimicrobial Therapy Group (IATG). Eur. J. Cancer 38(Suppl. 4), 82–87 (2002).
   PubMed Web of Science ®Google Scholar
• Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin. Infect. Dis. 40(Suppl. 4), 240–245 (2005).
   PubMed Web of Science ®Google Scholar
• Farthman EH, Schöffel U. Epidemiology and pathophysiology of intra-abdominal infections (IAI). Infection 26(5), 329–334 (1998).
   PubMedGoogle Scholar
• Jansen HH. Postmortem findings in peritonitis. Leber Magen Darm 11(4), 167–173 (1981).
   PubMedGoogle Scholar
• Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J. Intern. Med. 244(5), 379–386 (1998).
   PubMed Web of Science ®Google Scholar
• Luna CM, Vujacich P, Niedeman MS et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111(3), 676–685 (1997).
   PubMed Web of Science ®Google Scholar
• Kollef MH. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am. J. Med. 115(3), 1582–1584 (2003).
   Google Scholar
• Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 156(1), 196–200 (1997).
   PubMed Web of Science ®Google Scholar
• MacArthur RD, Miller M, Albertson T et al. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin. Infect. Dis. 38(2), 284–288 (2004).
   PubMed Web of Science ®Google Scholar
• Behrendt G, Schneider S, Brodt HR, Just-Nubling G, Shah PM. Influence of antimicrobial treatment on mortality in septicemia. J. Chemother. 11(3), 179–186 (1999).
   PubMed Web of Science ®Google Scholar
• Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5(1), 9–17 (1999).
   PubMed Web of Science ®Google Scholar
• Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1), 146–155 (2000).
   PubMed Web of Science ®Google Scholar
• National Nosocomial Infections Surveillance (NNIS). System report, data summary from January 1990–May 1999, issued June 1999. Am. J. Infect. Control 27(6), 520–532 (1999).
   PubMed Web of Science ®Google Scholar
• McGowan JE. Minimizing antimicrobial resistance: the key role of the infectious diseases physician. Clin. Infect. Dis. 38(7), 939–942 (2004).
   PubMed Web of Science ®Google Scholar
• Kish MA. Guide to development of practice guidelines. Clin. Infect. Dis. 32(6), 851–854 (2001).
   PubMed Web of Science ®Google Scholar
• McNulty CA. Optimising antibiotic prescribing in primary care. Int. J. Antimicrob. Agents 18(4), 329–333 (2001).
   PubMedGoogle Scholar
• Tamblyn R, Huang A, Perreault R et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. Can. Med. Assoc. J. 169(6), 549–556 (2003).
   PubMed Web of Science ®Google Scholar
• Mullett CJ, Thomas JG, Smith CL, Sarwari AR, Khakoo RA. Computerized antimicrobial decision support: an offline evaluation of a database-driven empiric antimicrobial guidance program in hospitalized patients with a bloodstream infection. Int. J. Med. Inform. 73(5), 455–460 (2004).
   PubMedGoogle Scholar
• Burgess DS, Hastings RW. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill. Diagn. Microbiol. Infect. Dis. 38(1), 37–41 (2000).
   PubMed Web of Science ®Google Scholar
• Burgess DS, Nathisuwan S. Cefepime, pipericillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. 44(1), 35–41 (2002).
   PubMed Web of Science ®Google Scholar
• Chamot E, Boffi El Amari E, Rohner P, Van Delden C. Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia. Antimicrob. Agents Chemother. 47(9), 2756–2764 (2003).
   PubMed Web of Science ®Google Scholar
• Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect. Dis. 4(8), 519–527 (2004).
   PubMed Web of Science ®Google Scholar
• Paul M, Soares-Weiser K, Grozinsky S, Leibovici L. β-lactam versus β-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia. Cochrane Database Syst. Rev. 3(CD003038) (2003).
   Google Scholar
• Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care Med. 29(6), 1109–1115 (2001).
   PubMed Web of Science ®Google Scholar
• Trouillet JL, Chastre J, Vuagnat A et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am. J. Respir. Crit. Care Med. 157(2), 531–539 (1998).
   PubMed Web of Science ®Google Scholar
• Rello J, Vidaur L, Sandiumenge A et al. De-escalation therapy in ventilator-associated pneumonia. Crit. Care Med. 32(11), 2183–2190 (2004).
   PubMed Web of Science ®Google Scholar
• Gruson D, Hilbert G, Vargas F et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria. Am. J. Respir. Crit. Care Med. 162(3), 837–843 (2000).
   PubMed Web of Science ®Google Scholar
• Gruson D, Hilbert G, Vargas F et al. Strategy of antibiotic rotation: long-term effect on the incidence and the susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia. Crit. Care Med. 31(7), 1908–1914 (2003).
   PubMed Web of Science ®Google Scholar
• Raymond DP, Pelletier SJ, Crabtree TD et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit. Care Med. 29(6), 1101–1108 (2001).
   PubMed Web of Science ®Google Scholar
• Byl B, Clevenbergh P, Jacobs F et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin. Infect. Dis. 29(1), 60–66 (1999).
   PubMed Web of Science ®Google Scholar
• Fowler VG, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious disease specialist: experience with 244 patients. Clin. Infect. Dis. 27(3), 478–486 (1998).
   PubMed Web of Science ®Google Scholar
• Borer A, Gilad J, Meydan N. Impact of regular attendance by infectious disease specialists on the management of hospitalised adults with community-acquired febrile syndromes. Clin. Microbiol. Infect. 10(10), 911–916 (2004).
   PubMed Web of Science ®Google Scholar
• Fluckiger U, Zimmmerli W, Sax H et al. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur. J. Clin. Microbiol. Infect. Dis. 19(7), 493–500 (2000).
   PubMed Web of Science ®Google Scholar
• Lemmen SW, Becker G, Frank U, Daschner FD. Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital. Scand. J. Infect. Dis. 33(3), 219–221 (2001).
   PubMedGoogle Scholar
• Lemmen SW, Hafner H, Kotterik S, Lutticken R, Topper R. Influence of an infectious disease service on antibiotic prescription behaviour and selection of multiresistant pathogens. Infection 28(6), 384–387 (2000).
   PubMed Web of Science ®Google Scholar